Search alternatives:
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
significant time » significant threat (Expand Search), significant cause (Expand Search), significant gap (Expand Search)
time decrease » time increased (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
significantly reported » significantly related (Expand Search), significantly restored (Expand Search), significantly predicted (Expand Search)
reported decrease » reported disease (Expand Search), reported depressive (Expand Search), reported case (Expand Search)
significant time » significant threat (Expand Search), significant cause (Expand Search), significant gap (Expand Search)
time decrease » time increased (Expand Search), sizes decrease (Expand Search), teer decrease (Expand Search)
-
41
-
42
Tumor volume and body weight of mice in control and CO<sub>2</sub>-treated groups.
Published 2023Subjects: -
43
-
44
Time to onset of AEs in male and female patients receiving finasteride therapy.
Published 2025Subjects: -
45
-
46
-
47
-
48
-
49
-
50
Supplementary Material for: Decrease in mycophenolic acid plasma level by sacubitril/valsartan in lupus nephritis patient: a case report
Published 2024“…Mycophenolate mofetil (MMF), an inactive prodrug of mycophenolic acid (MPA), is an immunosuppressive drug used widely in the treatment of lupus nephritis. In this case report, the area under the blood concentration time curve (AUC) of MPA was significantly decreased by the concomitant use of sacubitril/valsartan. …”
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60